baber/WOPTO huggingface dataset:
Patent AU-2017213653-A1 (AU)
Title: Tools for predicting the risk of preterm birth
Inventor: JELLIFFE LAURA
IPC: G01N33/68
Filed: 2017-02-04
Abstract: The invention is directed to methods and compositions of matter for predicting the risk of preterm birth (PTB) in a subject and administering interventions to subjects at elevated risk of PTB. The inventions provide a convenient, non-invasive, and accurate means of assessing PTB risk in a subject, and further provide a means of treating subjects in need of treatment and selecting appropriate interventions to reduce such risk. The diagnostic tools include novel panels of biomarkers and other factors which can be used to accurately predict risk of PTB across a population, wherein elevated risk is due to a variety of underlying physiological pathways and processes. In another aspect, the scope of the invention encompasses assay kits which are useful in the fast, accurate, and inexpensive prediction of PTB risk by multiplexed measurement of PTB risk factors.
Patent AU-2017222653-A1 (AU)
Title: Recombinant virus products and methods for inducing DUX4 exon skipping
Inventor: HARPER SCOTT QUENTON
IPC: C12Q1/68
Filed: 2017-02-24
Abstract: The present invention relates to methods for shifting the splicing profile of the DUX4 gene, a double homeobox gene on human chromosome 4q35. Recombinant adeno-associated viruses of the invention deliver DNAs encoding U7-based small nuclear RNAs to induce DUX4 exon- skipping and the expression of shortened forms of DUX4. The methods have application in the treatment of muscular dystrophies such as facioscapulohumeral muscular dystrophy.
Patent AU-2017233233-A1 (AU)
Title: Floating platform
Inventor: SKJOLDHAMMER JAN
IPC: F03B13/14
Filed: 2017-03-15
Abstract: A floating platform for a wave energy converter (WEC), comprising a hollow body, in which energy converting machinery may be positioned. The floating platform has an underside facing the water in use, an upper side facing the opposite direction and a first long-side forming a front and a second long-side forming a back, and two short-sides, at least one aligning means is provided, configured to align the front of the floating platform with the wave front, i.e. perpendicular to the direction of the wave, the front of the floating platform is at least 30 m long, the length of the front is at least two times the length of the side, the height of the floating platform is at least 1 m, wherein the floating platform is made up by means of a composite sandwich construction and the platform is configured to work in waves of deep sea shape at a sea depth of more than 1.3 times the highest probable monster wave in the relevant area.
Patent AU-2017245296-A1 (AU)
Title: Pharmaceutical compositions comprising alisporivir
Inventor: GONCALVES ELISABETE
IPC: A61K47/26
Filed: 2017-10-09
Abstract: I: \dar\Intrwovn\NRPortbl\DCC\DAR\15810840_l.docx-9 102017 Abstract The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
Patent AU-2017245419-A1 (AU)
Title: Insertable endoscopic instrument for tissue removal
Inventor: FURLONG COSME
IPC: A61B17/32
Filed: 2017-10-13
Abstract: An improved endoscopic instrument easily and efficiently obtains samples of multiple polyps from a patient by debriding one or more polyps and retrieving the debrided polyps without having to alternate between using a separate cutting tool and a separate sample retrieving tool and may be used with an endoscope. WO 2013/082602 PCT/US2012/067614 -CD Lr3 Lfci)
Patent AU-2017280298-A1 (AU)
Title: Compounded herbicidal composition containing Shuangzuocaotong and method of using the same
Inventor: PENG XUEGANG
IPC: C07D231/20
Filed: 2017-05-18
Abstract: Provided are a compounded weeding composition containing dicarfentrazone-ethyl, and a using method therefor. The compounded weeding composition comprises an active component A and an active component B, the active component A is dicarfentrazone-ethyl and the active component B is glyphosate or glufosinate, the weight proportion between the active component A and the active component B is 1:100-1 and preferentially 1:60-1. The compounded weeding composition has synergistic effects, and has very good activity on preventing resistance weeds.
Patent AU-2017292138-A1 (AU)
Title: Nicotine inhaler system
Inventor: ZUBER GERARD
IPC: A24F42/60
Filed: 2017-06-14
Abstract: An inhaler system suitable for providing nicotine particles includes a mouthpiece portion removably coupled to a distal end portion. The mouthpiece portion includes a capsule cavity and a mouthpiece air channel extending from the mouthpiece end to the capsule cavity. The distal end portion includes a piercing element coupled to the distal end portion and a resealable membrane configured to seal the capsule cavity when the mouthpiece portion is coupled to the distal end portion. The resealable membrane is configured to reseal when the piercing element moves out of the resealable membrane.
Patent AU-2017292615-A1 (AU)
Title: Rotary tensioner
Inventor: Leucht Volker
IPC: F02B67/06
Filed: 2017-06-19
Abstract: A tensioner comprising a base having a base aperture, the base aperture disposed to receive a driven component, a rotary arm pivotally engaged with the base, an axis of rotation of the rotary arm aligned with a base aperture center, a first pulley journalled to the rotary arm, a swing arm pivotally engaged with the rotary arm about a shaft, the shaft and swing arm each having cooperating frustoconical portions, a torsion spring biasing the pivot arm, a second pulley journalled to the swing arm, a bushing having a frustoconical portion in frictional engagement with the swing arm frustoconical portion, the bushing in fixed relation to the shaft or pivot arm, and a first damping ring frictionally engaged between the rotary arm and the base, a Belleville spring in pressing engagement whereby a normal force is applied to the first damping ring.
Patent AU-2017326466-A1 (AU)
Title: Ketone inhibitors of lysine gingipain
Inventor: KONRADI ANDREW W
IPC: C07D417/12
Filed: 2017-09-15
Abstract: The present invention provides compounds according to Formula (I) as described herein, and their use for inhibiting the lysine gingipain protease (Kgp) from the bacterium
Patent AU-2017340125-A1 (AU)
Title: Slip control system for an off-road vehicle
Inventor: FOSTER CHRISTOPHER A
IPC: A01B63/112
Filed: 2017-04-03
Abstract: A slip control system for an off-road vehicle includes a control system (26) configured to output a signal indicative of a first action (102, 104, 106, 108, 118, 120) if a magnitude of slippage (80) of the off-road vehicle relative to a soil surface is greater than a first threshold value (86) and less than or equal to a second threshold value. Furthermore, the control system is configured to output a signal indicative of a second action (102, 104, 106, 108, 118, 120), different than the first action, if the magnitude of slippage (80) is greater than the second threshold value (86).
Patent AU-2017368201-A1 (AU)
Title: Semi-trailer, trailer truck and method for braking a semi-trailer
Inventor: DREWES OLAF
IPC: B60L9/16
Filed: 2017-11-28
Abstract: The invention relates to a semi-trailer, comprising a wheel and an electric machine for driving the wheel, wherein the electric machine is configured in such a way that it can be operated as an electric motor brake in a braking state.
Patent AU-2017412145-A1 (AU)
Title: Aqueous polymer dispersion
Inventor: LI YAN
IPC: C08F220/18
Filed: 2017-04-24
Abstract: Provided are an aqueous polymer dispersion, a process of preparing the aqueous polymer dispersion, an aqueous coating composition comprising the aqueous polymer dispersion and forming coatings with improved water repellency and/or improved hydrophobic stain resistance without compromising hydrophilic stain resistance.
Patent WO-2019109132-A1 (WO)
Title: Composés d'isoxazolyle utilisés en tant que composés modulateurs du récepteur, procédés et utilisations de ceux-ci
Inventor: RIPPER JUSTIN ANTHONY
IPC: C07D261/10
Filed: 2018-11-26
Abstract: La présente invention concerne d'une manière générale des composés chimiques et des procédés d'utilisation et de préparation de ceux-ci. La présente invention concerne particulièrement, des composés chimiques utiles dans le traitement de maladies, de troubles ou d'états pathologiques qui pourraient bénéficier de la modulation du récepteur nicotinique de l'acétylcholine alpha 7 (α7 nAChR). L'invention concerne également l'utilisation de ces composés dans des méthodes thérapeutiques et la fabrication de médicaments ainsi que des compositions contenant ces composés.
Patent AU-2018202854-A1 (AU)
Title: Dosage regimen for a S1P receptor agonist
Inventor: SCHMOUDER ROBERT
IPC: A61K31/137
Filed: 2018-04-24
Abstract: 1: \dar\Interwoven\NRPortbl\DCC\DAR\16849577_l.docx-23 04/2018 S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
Patent AU-2018206796-A1 (AU)
Title: Wet leakage current test system for photovoltaic component
Inventor: MA SHENGTAO
IPC: H02S50/10
Filed: 2018-06-15
Abstract: The present disclosure discloses a wet leakage current test system for a photovoltaic component, comprising a liquid pool and a voltage-withstanding insulation tester as well as a first storage rack, a lifting actuator, a second storage rack, a drying apparatus and an electrical protection device; the first storage rack is arranged above the liquid pool, and is mechanically connected with the lifting actuator; the lifting actuator is configured to drive the first storage rack to descend into the liquid pool or ascend above the liquid pool; the drying apparatus is mounted on the second storage rack, for blowing air to a front surface and a back surface of the photovoltaic component laid flat on the second storage rack; and the electrical protection device is in electrical signal connection with the voltage-withstanding insulation tester, for disabling a voltage output from the voltage-withstanding insulation tester in the case that the operator operates in a high voltage region, and/or for cutting off a power source of the voltage-withstanding insulation tester in an emergency. The present disclosure can reduce human burden, save labor costs, improve test and production efficiencies, further eliminate safety hazards and ensure the reliability and safety during the test. - 22 -
Patent AU-2018213369-A1 (AU)
Title: Centrifugal pump assemblies having an axial flux electric motor and methods of assembly thereof
Inventor: TURNER MATTHEW J
IPC: F04B17/04
Filed: 2018-01-26
Abstract: An electric motor assembly for pumping a fluid through a fluid cavity includes a stator assembly including a plurality of conduction coils configured to transmit heat energy to the fluid within the fluid cavity and a rotor assembly positioned adjacent the stator assembly to define an axial gap therebetween. The stator assembly is configured to impart a first axial force on the rotor assembly. The electric motor assembly also includes an impeller directly coupled to the rotor assembly opposite the stator assembly such that the rotor assembly and the impeller are configured to rotate about an axis. A fluid channeled by the impeller imparts a second axial force on the impeller. The rotor assembly and the impeller are configured to be submerged in the fluid within the fluid cavity.
Patent AU-2018223879-A1 (AU)
Title: An inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease
Inventor: WENGNER ANTJE MARGRET
IPC: C12Q1/6886
Filed: 2018-02-22
Abstract: The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H- pyrazol-5-yl)-1,7-naphthyridine (in the following called "Compound A"), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject. Preferably the hyper-proliferative disease or the subject is characterized by one or more biomarker(s) selected from a) one or more functional mutation(s) in one or more gene(s)/protein(s) selected from APC, ATG5, ARID1A, ATM, ATR, ATRIP, ATRX, BAP1, BARD1, BLM, BRAF, BRCA1, BRCA2, BRIP1, CCND1, CCNE1, CCNE2, CDC7, CDK12, CHEK1, CHEK2, DCLRE1A, DCLRE1B, DCLRE1C, DYRK1A, EGFR, ERBB2, ERBB3, ERCC2, ERCC3, ERCC4, ERCC5, FAM175A, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FBXO18, FBXW7, FEN1, GEN1, HDAC2, H2AFX, HRAS, KRAS, LIG4, MDC1, MLH1, MLH3, MRE11A, MSH2, MSH3, MSH6, MYC, NBN, NRAS, PALB2, PARP1, PARP2, PARP3, PARP4, PCNA, PIK3CA, PMS2, POLA1, POLB, POLH, POLL, POLN, POLQ, PRKDC, PTEN, RAD9A, RAD17, RAD18, RAD50, RAD51, RAD52, RAD54B, RAD54L, RB1, REV3L, RPA1, RPA2, SLX4, TDP1, TDP2, TMPRSS2, TMPRSS2-ERG, TOPBP1, TOP2A, TOP2B, TP53, TP53BP1, TRRAP, UBE2N, UIMC1, USP1, WDR48, WRN, XPA, XRCC1, XRCC2, XRCC3, XRCC4 and/or XRCC6 gene/protein; and/or b) the activation of the ALT pathway; and/or c) microsatellite instability. The present invention also covers a kit comprising Compound A together with means to detect one or more of the aforementioned biomarker(s) and a method for identifying a subject having a hyper- proliferative disease disposed to respond favorably to Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s). Further, the invention covers a method of determining whether a subject having a hyper-proliferative disease will respond to the treatment with Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s) in a sample of the subject.
Patent AU-2018229693-A1 (AU)
Title: Rib, wall, slope and roof safety system
Inventor: KATHAGE WADE
IPC: E01F7/04
Filed: 2018-03-21
Abstract: A deflection system and containment system are provided. The deflection system is for deflecting debris falling from a wall or roof. The deflection system comprises: two or more anchors; a support line extending between the anchors; and a deflection net, supported by the support line and spaced from the wall or roof, and configured to deflect debris falling from the wall or roof.
Patent AU-2018231597-A1 (AU)
Title: Device, apparatus and method of determining skin perfusion pressure
Inventor: BROWNHILL VARUNI RACHINDRA
IPC: A61B5/02
Filed: 2018-03-09
Abstract: Disclosed embodiments relate to apparatuses and methods for a skin perfusion pressure determination device. In some embodiments, a skin perfusion pressure determination device can include a sensor module having a first sensor for sensing a first parameter associated with a pressure exerted on a target area by the sensor module and a second sensor for sensing a second parameter associated with an amount of blood perfusion at the target area. In some embodiments, the first sensor and the second sensor can be arranged such that, when the sensor module is pressed against the target area the first sensor produces an output corresponding to the sensed first parameter and the second sensor produces an output corresponding to the sensed second parameter.
Patent AU-2018241103-A1 (AU)
Title: Abiraterone Acetate Formulation
Inventor: BOSCH H WILLIAM
IPC: A61P35/00
Filed: 2018-10-04
Abstract: Pharmaceutical compositions, including unit dosage forms, comprising fine particle abiraterone acetate with or without an antioxidant and or a sequesting agent as well as methods for producing and using such compositions are described.
Patent AU-2018244047-A1 (AU)
Title: Anti-GPR20 antibody
Inventor: IIDA KENJI
IPC: C12N1/15
Filed: 2018-03-29
Abstract: The present invention addresses the problem of providing: an anti-GPR20 antibody that can be used to detect GPR20; a reagent for detecting GPR20 comprising said antibody; and a diagnostic reagent, test composition, etc., for a disease associated with expression of GPR20. Provided are: an antibody that binds specifically to a peptide comprising an amino acid sequence indicated by amino acids 1 through 48 in SEQ ID NO: 1, or an antigen-binding fragment of said antibody; a chimerized antibody, rabbitized antibody, etc., of said antibody; and a composition, etc., comprising said antibody.
Patent AU-2018247816-A1 (AU)
Title: Proteins derived from ClpB and uses thereof
Inventor: FETISSOV SERGUEI
IPC: A61K38/16
Filed: 2018-04-03
Abstract: The present invention relates to polypeptides and proteins comprising a fragment of a ClpB protein and compositions therefrom. The present invention also relates to the treatment and/or prevention of inflammation, in particular overweight and/or obesity-related diseases and disorders. The present invention also relates to methods of inducing satiation, prolonging satiety, reducing meal size, reducing food intake, controlling weight gain and stimulating weight loss.
Patent AU-2018256508-A1 (AU)
Title: Individualized vaccines for cancer
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2018-10-30
Abstract: The present invention relates to a patient-specific tumour treatment targeting individual expression patterns of tumour antigens, in particular shared tumour antigens, and individual tumour mutations. In one aspect, the present invention relates to a method for preventing or treating cancer in a patient comprising the steps of: (i) inducing a first immune response against one or more tumour antigens in the patient, and (ii) inducing a second immune response against one or more tumour antigens in the patient wherein the second immune response is specific for cancer specific somatic mutations present in cancer cells of the patient.
Patent AU-2018257685-A1 (AU)
Title: Clothing processing apparatus, control method of clothing processing apparatus, and online system including clothing processing apparatus
Inventor: KWON BAEKEUN
IPC: D06F33/02
Filed: 2018-04-18
Abstract: The present invention relates to a clothing processing apparatus comprising a control unit which can pre-store a recommendation formula and thus can autonomously calculate and determine a course and option to be recommended.
Patent AU-2018261792-A1 (AU)
Title: Methods for treatment of alport syndrome
Inventor: WRIGHT TIMOTHY
IPC: A61K31/7125
Filed: 2018-05-04
Abstract: Provided herein are methods for the treatment of Alport syndrome, using a modified oligonucleotide targeted to miR-21. In certain embodiments, the modified oligonucleotide targeted to miR-21 improves kidney function and/or reduces fibrosis in subjects having Alport syndrome. In certain embodiments, administration of the modified oligonucleotide targeted to miR-21 delays the onset of end-stage renal disease in a subject having Alport syndrome. In certain embodiments, the modified oligonucleotide targeted to miR-21 delays the need for dialysis or kidney transplant in a subject having Alport syndrome.
Patent AU-2018278926-A1 (AU)
Title: Integrated electrochemical compressor and cascade storage method and system
Inventor: PRESCOTT ADAM
IPC: H01M8/06
Filed: 2018-12-12
Abstract: A method of maintaining pressure within a compressed fuel storage system, the method comprising: compressing a fuel source with a compressor; directing fuel from the compressor to a first fuel reservoir; determining that the first fuel reservoir has reached a target fill pressure; transiting from the first fuel reservoir to a second fuel reservoir by redirecting the fuel to the second fuel reservoir; and opening a flow limiting valve to limit the rate of pressure change of the compressor to an allowable rate of pressure change when transitioning from the first fuel reservoir to the second fuel reservoir. ----- -------- - - - - - - - - * I I * I L 0-- --- --- - -- - - - - - I Op * I I - b C%4 1/2*
Patent AU-2018290176-A1 (AU)
Title: Trailing suction hopper dredger having a recycle system for effluent and method for suction dredging
Inventor: NEELISSEN ROELAND FREDERIK JOHANNES
IPC: E02F3/88
Filed: 2018-06-21
Abstract: Trailing suction hopper dredger, comprising a hopper and a suction pipe extending from the hopper, wherein a suction head is provided at an end of the suction pipe, and an outlet at an opposite end for disposing dredging sludge into the hopper. At least one jet pipe is connected to the suction head for jetting water into a suction chamber of the suction head through at least one jet and a recycle line is provided between the hopper and the suction head for feeding effluent from the hopper to the suction head. The recycle line has at least one outlet at side of, preferably at opposite sides outside the suction chamber, such that effluent flowing out of the said outlet is sucked into the said suction chamber and/or at least one outlet, opening into the suction chamber of the suction head, near a trailing end of the suction head.
Patent AU-2018292807-A1 (AU)
Title: Method and system for delivering biodegradable shelled portions
Inventor: ALKAHER SHLOMO
IPC: B64D1/16
Filed: 2018-06-26
Abstract: A method of delivering over the air, shelled portions of fluids or granular substances containing effective ingredients, to a target, includes the following stages: selecting a type and a size of the shelled portions containing the required effective ingredients, based on mission parameters and physical data of a scene containing the target; conveying the shelled portions to a delivery point, based on the mission parameters and the physical data; and ballistically delivering the shelled portions towards the target, wherein the shelled portions comprise fluids or granular substances covered by shells made of: a first layer comprising polysaccharide and a polymer matrix, the first layer being configured to form a water barrier when in contact with water; a second layer comprising a polysaccharide and a polymer matrix; and a third layer comprising polysaccharide, a polymer matrix and an additive configured to accelerate disintegration of the polymeric shell.
Patent AU-2018337040-A1 (AU)
Title: Systems and methods for time-based one-time password management for a medical device
Inventor: AGNELLO ALESSANDRO SIMONE
IPC: H04L29/08
Filed: 2018-09-18
Abstract: A data monitoring system comprising a server communicatively coupled to a client device and a data module via a network. The server is configured to store a private key of a public-private key pair associated with the data module, receive a request from the client device for authenticated access to the data module, and generate an authentication key based at least on the private key and a time. The client device is configured to generate the request for authenticated access to the data module and transmit the request to the server. The data module is configured to store the private key of the public-private key pair associated with the data module, generate the authentication key based at least on the private key and the time, and grant access to the data module if the authentication key generated by the data module and the authentication key generated by the server match.
Patent AU-2018374539-A1 (AU)
Title: Solid forms of a plasma kallikrein inhibitor and salts thereof
Inventor: CROWE DAVID MALCOLM
IPC: C07D401/14
Filed: 2018-11-29
Abstract: The present invention relates to new solid forms of a plasma kallikrein inhibitor, a pharmaceutical composition containing them and their use in therapy. Also provided are processes for preparing the solid forms of the present invention.